Paper41008883
Tumour-Infiltrating Lymphocytes, Tumour Cell Density, and Response to Neoadjuvant Short-Course Radiotherapy in Rectal Cancer: A Translational Sub-Study from the MRC CR07 Clinical Trial.
Callaghan JP and 11 others. Cancers (Basel), 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Tumour-Infiltrating Lymphocytes, Tumour Cell Density, and Response to Neoadjuvant Short-Course Radiotherapy in Rectal Cancer: A Translational Sub-Study from the MRC CR07 Clinical Trial. Papers, record 41008883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumour-Infiltrating Lymphocytes, Tumour Cell Density, and Response to Neoadjuvant Short-Course Radiotherapy in Rectal Cancer: A Translational Sub-Study from the MRC CR07 Clinical Trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RRCOER-Jun24/100004 | Cancer Research UK | United Kingdom | PubMed | |
| NIHR203331 | National Institute for Health Research | PubMed |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33223535 | The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer. | Br J Cancer | 2021 | https://conductscience.org/library/papers/33223535 | PubMed |
| 2 | 30284239 | Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/30284239 | PubMed |
| 3 | 31869737 | The local inflammatory response in colorectal cancer - Type, location or density? A systematic review and meta-analysis. | Cancer Treat Rev | 2020 | https://conductscience.org/library/papers/31869737 | PubMed |
| 4 | 37345012 | Tumor-Stroma Ratio in Colorectal Cancer-Comparison between Human Estimation and Automated Assessment. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37345012 | PubMed |
| 5 | 30116024 | A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. | Br J Cancer | 2018 | https://conductscience.org/library/papers/30116024 | PubMed |
| 6 | 33008040 | Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33008040 | PubMed |
| 7 | 36403589 | Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision. | Lancet Healthy Longev | 2022 | https://conductscience.org/library/papers/36403589 | PubMed |
| 8 | 40293274 | Prognostic Value of CD8+ T Cells at the Invasive Margin Is Comparable to the Immune Score in Nonmetastatic Colorectal Cancer: A Prospective Multicentric Cohort Study. | Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40293274 | PubMed |
| 9 | 19269519 | Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. | Lancet | 2009 | https://conductscience.org/library/papers/19269519 | PubMed |
| 10 | 36238289 | The immune microenvironment landscape shows treatment-specific differences in rectal cancer patients. | Front Immunol | 2022 | https://conductscience.org/library/papers/36238289 | PubMed |
| 11 | 33678606 | Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/33678606 | PubMed |
| 12 | 34868930 | Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review. | Front Oncol | 2021 | https://conductscience.org/library/papers/34868930 | PubMed |
| 13 | 34533595 | Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study. | Int J Colorectal Dis | 2021 | https://conductscience.org/library/papers/34533595 | PubMed |
| 14 | 32099066 | The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis. | Sci Rep | 2020 | https://conductscience.org/library/papers/32099066 | PubMed |
| 15 | 31543678 | Neoadjuvant radiotherapy for rectal cancer management. | World J Gastroenterol | 2019 | https://conductscience.org/library/papers/31543678 | PubMed |
| 16 | 30559429 | U-Net: deep learning for cell counting, detection, and morphometry. | Nat Methods | 2019 | https://conductscience.org/library/papers/30559429 | PubMed |
| 17 | 39948076 | Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial. | Sci Rep | 2025 | https://conductscience.org/library/papers/39948076 | PubMed |
| 18 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 19 | 34123856 | Prognostic Value of Tumor-Stroma Ratio in Rectal Cancer: A Systematic Review and Meta-analysis. | Front Oncol | 2021 | https://conductscience.org/library/papers/34123856 | PubMed |
| 20 | 40033106 | Deep-learning enabled combined measurement of tumour cell density and tumour infiltrating lymphocyte density as a prognostic biomarker in colorectal cancer. | BJC Rep | 2025 | https://conductscience.org/library/papers/40033106 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42449690 | Lactate Dehydrogenase-5 and Tumor-Infiltrating Lymphocytes in Prostate Cancer Patients Undergoing Radical Hypofractionated Radiotherapy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449690 | PubMed |
| 42449633 | Tumour-Stroma Ratio as a Predictive Biomarker for Neoadjuvant Therapy Efficacy in Rectal Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449633 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41008883
GET https://conductscience.org/api/papers/v1/41008883/references?page=2